Showing 1 - 11 results of 11 for search 'Xue-Qiang Hu', query time: 0.07s
Refine Results
-
1
Diagnosis and treatment of cryptococcal meningitis and/or cryptococcal meningoencephalitis by Yan-yu CHANG, Xue-qiang HU
Published 2014-08-01
Article -
2
-
3
Research progress of idiopathic inflammatory demyelinating diseases by Xiao-nan ZHONG, Xue-qiang HU
Published 2018-02-01
Article -
4
Axonal injury and its mechanisms in multiple sclerosis by Xue⁃qiang HU, Xiao⁃nan ZHONG
Published 2012-04-01
Article -
5
Progress in diagnosis of neuromyelitis optica by Xiao⁃nan ZHONG, Xue⁃qiang HU
Published 2012-04-01
Article -
6
Advances in the study on pathologic mechanism and treatment of autoimmune diseases in nervous system by You⁃ming LONG, Xue⁃qiang HU
Published 2010-02-01
Article -
7
Is Syphilis a Potential New Factor of the POEMS Syndrome? by Jun-Jie Yin, Ai-Min Wu, Zhi-Feng Mao, Zheng-Qi Lu, Xue-Qiang Hu
Published 2015-01-01
Article -
8
-
9
The projection from the prelimbic cortex to the ventral tegmental area negatively regulates 5-HT-induced itch-scratching and positively regulates itch-related aversion in rats by Xing-Yu Lu, Jun-Fei Teng, Juan Yao, Xuan Li, Bing Wu, Xue-Qiang Hu, Ping Wang, Xiao-Qian Jiang, Jian-Feng Sui, Ke-Hui Hu, Yue-Ming Xu, Shu-Lei Liu
Published 2025-04-01
Article -
10
The projection from the rostral anterior cingulate cortex to the ventral tegmental area regulates 5-HT-induced itch aversion and scratching in rats by Jun-Fei Teng, Xing-Yu Lu, Jun-Hui Long, Ying Shi, Xue-Qiang Hu, Jian-Feng Sui, Ping Wang, Lian-Lin Zeng, Xuan Li, Jin-He Xu, Zu-Zhen Ou, Ke-Hui Hu, Shu-Lei Liu
Published 2025-04-01
Article -
11
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study by Wei Qiu, De-Hui Huang, Shi-Fang Hou, Mei-Ni Zhang, Tao Jin, Hui-Qing Dong, Hua Peng, Chao-Dong Zhang, Gang Zhao, Yi-Ning Huang, Dong Zhou, Wei-Ping Wu, Bao-Jun Wang, Ji-Mei Li, Xing-Hu Zhang, Yan Cheng, Hai-Feng Li, Ling Li, Chuan-Zhen Lu, Xu Zhang, Bi-Tao Bu, Wan-Li Dong, Dong-Sheng Fan, Xue-Qiang Hu, Xian-Hao Xu, for the TOWER Trial Chinese Group
Published 2018-01-01
Article